Skip to content

NOTICIERO VOIDVOID TERMINAL

AI Web3 Crypto Stocks Finance Macro Prediction Markets Technology Markets Newsletter

PRO

Front page › Stocks

Stocks

Revolution Medicines rises on Q3 beats; maintains 2026 guidance

Seeking Alpha4 Nov 2026, 23:19 UTC

Read the full story at Seeking Alpha

Related

Agilon raises 2026 outlook to $5.88B revenue and $150M adjusted EBITDA while expecting 40%-50% ACO membership growth in 2027 Seeking Alpha
Timken expects mid-single-digit 2027 organic sales growth as it raises 2026 adjusted EPS outlook to $6.35-$6.50 Seeking Alpha
HP Inc. president Anneliese Olson sells $618,542 in shares Investing.com
Boundless Bio director Kevin Tang buys $25,696 in shares Investing.com
ATN International earnings beat by $0.91, revenue fell short of estimates Investing.com
Liberty Latin America C earnings missed, revenue fell short of estimates Investing.com
Solstice outlines $4.195B-$4.22B 2026 sales outlook and plans to finish remaining $400M buyback by Q1 2027 Seeking Alpha
Traeger narrows FY 2026 outlook to $440M-$460M revenue as it expects Q4 return to YoY growth, supported by Lowe’s load-in Seeking Alpha

Economy & Central Banks · AI · Markets · Crypto · Web3 · Stocks · Technology · Finance · Commodities · Currencies · Geopolitics · All news · About · Editorial policy · Privacy

NOTICIERO VOID ·

Economy · Markets · Crypto · Commodities · Currencies · Geopolitics · About · Editorial policy · Privacy · RSS

Data: FRED (St. Louis Fed), U.S. Treasury FiscalData, Federal Reserve, ECB, BEA, CoinGecko, DefiLlama, GeckoTerminal, OKX, Solana RPC and publisher RSS feeds. Headlines link to the original publishers. Keyboard: g then t/m/n/c to jump · / search.